Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective

• Caroline S. Clarke ,

  * E-mail: caroline.clarke@ucl.ac.uk

  Affiliation UCL Research Department of Primary Care and Population Health, University College London, London, United Kingdom

  http://orcid.org/0000-0002-4676-1257

  ⨯
• Rachael M. Hunter,

  Affiliation UCL Research Department of Primary Care and Population Health, University College London, London, United Kingdom

  ⨯
• Ian Shemilt,

  Affiliation UCL Institute of Education, University College London, London, United Kingdom

  ⨯
• Victoria Serra-Sastre

  Affiliation Department of Economics, City, University of London, London, United Kingdom

  ⨯